EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY 4.0

Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes

Matteo Rinaldi iD, Ilaria Rancan iD, Federica Malerba, Milo Gatti iD, Leonardo Ancillotti, Beatrice Tazza, Caterina Campoli, Cecilia Bonazzetti iD, Beatrice Profiti, Natascia Caroccia, Simone Ambretti, Mario Tumbarello und 2 weitere

Journal of Antimicrobial Chemotherapy · 01.08.2025 · 80 (8) · 2247-2256

DOI: 10.1093/jac/dkaf197 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 19.06.2025. Verfasst von Matteo Rinaldi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Enterococcus faecium, Bacteremia, Gram-Positive Bacterial Infections, Anti-Bacterial Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Optimal management of Enterococcus faecium bloodstream infection (BSI) is not fully understood.

Methods

Multicentre retrospective observational study of all consecutive adult (≥18 years old) patients with E. faecium BSI, between January 2016 and December 2023, at two tertiary teaching hospitals in northern Italy. Patients who died within 48 h from BSI onset were excluded. Primary and secondary endpoints were 30 day mortality and persistent E. faecium BSI, respectively. Cox regression and logistic binary analyses were used.

Results

Overall, 391 patients were enrolled: median age was 72 (IQR 61–81) years, 225 were male (57.5%), median Charlson comorbidity index (CCI) was 6 (IQR 4–8) and 94 had immunosuppression (24.0%). BSIs were primary, secondary and device-related in 25.1%, 36.2% and 38.7%, respectively. Vancomycin resistance was found in 30.3%. The appropriate empirical therapy rate was given for 29.1%. All-cause 30 day mortality was 34.3% and the rate of persistent BSI was 18.8%. Variables independently associated with 30 day mortality were immunosuppression (HR 1.638, 95% CI 1.022–2.625, P = 0.040), SOFA (HR 1.205, 95% CI 1.144–1.268, P < 0.001), primary BSI (HR 1.839, 95% CI 1.221–2.770, P = 0.004), source control (HR 0.534, 95% CI 0.260–0.972, P = 0.042) and the performance of follow-up blood cultures (HR 0.403, 95% CI 0.280–0.972, P < 0.001). Factors independently associated with persistent E. faecium BSI were: CCI (OR 1.157, 95% CI 1.030–1.300, P = 0.014), source control not performed (OR 3.275, 95% CI 1.113–9.635, P = 0.031) and teicoplanin (OR 2.023, 95% CI 1.018–4.018, P = 0.044).

Conclusions

Among modifiable clinical factors in patients with E. faecium BSI, source control and the execution of follow-up blood cultures demonstrated a protective effect on 30 day mortality. Teicoplanin as targeted antibiotic treatment was independently associated with persistent BSI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Enterococcus faeciumBacteremiaGram-Positive Bacterial InfectionsAnti-Bacterial AgentsHumansMaleFemaleAgedRetrospective StudiesMiddle AgedRisk FactorsAged, 80 and overItalyTreatment OutcomeTertiary Care Centers

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Medical and Surgical Sciences, Alma Mater Studiorum University of Bologna, Bologna, Italy.
  • Department for Integrated Risk Management, Infectious Disease Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department of Medical Biotechnologies, University of Siena, Siena, Italy.
  • Department of Medical Sciences, Infectious and Tropical Diseases Unit, Siena University Hospital, Siena, Italy.
  • Clinical Pharmacology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
  • Department for Integrated Infectious Risk Management, Operative Unit of Microbiology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.

ORCID-Profile: Matteo Rinaldi, Ilaria Rancan, Milo Gatti, Cecilia Bonazzetti

Zitieren

APA

Rinaldi, M., Rancan, I., Malerba, F., Gatti, M., Ancillotti, L., Tazza, B., Campoli, C., Bonazzetti, C., Profiti, B., Caroccia, N., Ambretti, S., Tumbarello, M., Viale, P., & Giannella, M. (2025). Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes. Journal of Antimicrobial Chemotherapy, 80(8), 2247-2256. https://doi.org/10.1093/jac/dkaf197

Vancouver

Rinaldi M, Rancan I, Malerba F, Gatti M, Ancillotti L, Tazza B, et al. Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes. Journal of Antimicrobial Chemotherapy. 2025;80(8):2247-2256. doi:10.1093/jac/dkaf197

BibTeX
@article{Rinaldi2025,
  author = {Rinaldi, Matteo and Rancan, Ilaria and Malerba, Federica and Gatti, Milo and Ancillotti, Leonardo and Tazza, Beatrice and Campoli, Caterina and Bonazzetti, Cecilia and Profiti, Beatrice and Caroccia, Natascia and Ambretti, Simone and Tumbarello, Mario and Viale, Pierluigi and Giannella, Maddalena},
  title = {Enterococcus faecium bacteraemia: a multicentre observational study focused on risk factors for clinical and microbiological outcomes},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {8},
  pages = {2247--2256},
  doi = {10.1093/jac/dkaf197}
}
Kostenlos starten →